Citric Acid

Citric Acid

SCHEMBL535786

CC1CCN(O)C(C)(O)C1(C)C.CC1CCN(O)C(C)(O)C1(C)C.CC1CCN(O)C(C)(O)C1(C)C.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31300000 0.81 ALDH1A1 (0.37) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL2293604 0.76 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL2396390 0.65 ALDH1A1 (0.88) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL28167196 0.65 ALDH1A1 (0.88) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL30359537 0.65 ALDH1A1 (0.88) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL3417188 0.65 ALDH1A1 (1.00) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL240402 0.65 ALDH1A1 (1.00) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL10896997 0.65 ALDH1A1 (1.00) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL1331942 0.65 ALDH1A1 (1.00) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL842 0.65 ALDH1A1 (1.00) ALDH1A1KDM4ELMNAMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435175-B2 Melamine-formaldehyde foam with improved weather resistance BASF SE (DE) 2025-10-07 US claimed
WO-2025202160-A1 CLEANING COMPOSITIONS COMPRISING UV LIGHT STABILIZERS BASF SE (DE) 2025-10-02 WO claimed
WO-2025149495-A1 A HIGH SPF GEL COMPOSITION COMPRISING NIACINAMIDE UNILEVER IP HOLDINGS B.V. (NL) 2025-07-17 WO claimed
EP-4543409-A1 STABILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME L'OREAL (FR) 2025-04-30 EP claimed
US-12257332-B2 Prevention of the oxidation of perfumery raw materials FIRMENICH SA (CH) 2025-03-25 US claimed
WO-2024256011-A1 STABILIZER OR STABILIZER COMPOSITION FOR STABILIZING DIHYDROAVENANTHRAMIDE D SYMRISE AG (DE) 2024-12-19 WO claimed
CN-119033623-A Guaiac azulene liposome and preparation method and application thereof 江门职业技术学院 2024-11-29 CN claimed
CN-118986777-A Nanometer liposome protective agent with ultraviolet resistance and oxidation resistance functions, preparation method, preparation and application thereof 江门职业技术学院 2024-11-22 CN claimed
EP-4452206-A1 COSMETIC COMPOSITION COMPRISING INDIRUBIN AND A MIXTURE OF ANTIOXIDANTS Laboratoires Clarins (FR) 2024-10-30 EP claimed
CN-118319820-B Composition with whitening and skin brightening effects and preparation method thereof 广州旭妆生物科技有限公司 2024-08-30 CN claimed
EP-1994921-A1 Fragrance composition comprising the combination of one filter A hydroxyaminobenzophenone, one filter B cinnamate and of one compound C piperidinole, benzotriazole or dibenzoylmethane L'Oreal (FR) 2008-11-26 EP claimed
US-7431917-B2 Photostable photoprotective compositions comprising dibenzoylmethane and bis-resorcinyl triazine compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2008-10-07 US claimed
US-7357920-B2 Photostable photoprotective compositions comprising dibenzoylmethane and amide oil compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2008-04-15 US claimed
US-7357919-B2 Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2008-04-15 US claimed
US-20060104924-A1 Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2006-05-18 US claimed
EP-1649900-A2 Light screening composition comprising a derivative of dibenzoylmethane, a bis-resorcinyl triazine and a compound capable of accepting energy of the excited triplet state of dibenzoylmethane; process for photostabilisation L'OREAL (FR) 2006-04-26 EP claimed
EP-1649902-A2 Light screening composition comprising a dibenzoylmethane derivative, an arylalkyl benzoat derivative and a compound capable of accepting energie from the excited triplet state of dibenzoylmethane; process of photostabilisation L'OREAL (FR) 2006-04-26 EP claimed
EP-1649901-A2 Light screening composition comprising a dibenzoylmethane derivative, a lipophilic amide and a compound capable of accepting energy from the excited triplet state of dibenzoylmethane; process for photostabilsation L'OREAL (FR) 2006-04-26 EP claimed
US-20060083698-A1 Photostable photoprotective compositions comprising dibenzoylmethane and amide oil compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2006-04-20 US claimed
US-20060083699-A1 Photostable photoprotective compositions comprising dibenzoylmethane and bis-resorcinyl triazine compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) L'OREAL (FR) 2006-04-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060083699-A1 Photostable photoprotective compositions comprising dibenzoylmethane and bis-resorcinyl triazine compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) DHPS, DDT, CUTA ALDH1A1 459/4885KDM4E 342/4885LMNA 3944/4885
US-20060083698-A1 Photostable photoprotective compositions comprising dibenzoylmethane and amide oil compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) NOTUM, CUTA, WEE1 ALDH1A1 753/4885KDM4E 1797/4885LMNA 4109/4885
US-20060104924-A1 Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s) DDT, TYR, CUTA ALDH1A1 290/4885KDM4E 1271/4885LMNA 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.